The latest research study “Contraceptive Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global contraceptive drugs market size reached US$ 14.07 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 19.82 Billion by 2027, exhibiting a growth rate (CAGR) of 5.70% during 2022-2027.
Contraceptive drugs represent birth control medications that are exclusively prepared to inhibit pregnancy and control the birth rate. They are available in various product categories, such as oral pills, injectables, topical solutions, etc. These contraceptive drugs are synthetically formulated using two female hormones, which include estrogen and progestin, that prevent ovulation, thicken cervical mucus, or alter the womb lining to restrict the entrance of sperm into the cervix for implantation and fertilization. They prove highly effective in lowering the risks of ovarian cancer, bone thinning, infections in the fallopian tubes and uterus, acne, and premenstrual syndrome (PMS). Consequently, contraceptive drugs are administered by healthcare practitioners to avert unwanted pregnancy amongst women of childbearing age.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/contraceptive-drugs-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Contraceptive Drugs Market Trends and Drivers:
The expanding population, the elevating consumer consciousness regarding family planning, and the rising instances of unintended pregnancies are primarily driving the contraceptive drugs market. Furthermore, the shifting preferences among healthcare practitioners toward modern contraceptive procedures over conventional ones, on account of their multiple benefits, including optimal safety and enhanced clinical outcomes, are acting as significant growth-inducing factors. Besides this, the increasing rates of approvals of novel medications by several government bodies are also positively influencing the global market. Moreover, the launch of non-hormonal vaginal gels and gelatin capsules that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is further catalyzing the market growth. Apart from this, the inflating investments in research and development (R&D) activities and the introduction of numerous initiatives by non-governmental organizations (NGOs) and health agencies to sensitize consumers about women’s health, sexual wellness, and contraception techniques are expected to propel the contraceptive drugs market in the coming years.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/contraceptive-drugs-market
Contraceptive Drugs Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.
The report has segmented the market on the basis of product, age group and distribution channel.
Breakup by Product:
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
Breakup by Age Group:
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
Breakup by Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- Online Channel
- Public Channel and NGOs
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.